Movers and Shakers news roundup

  • 23 July 2021
Movers and Shakers news roundup

Our latest Movers and Shakers news roundup features a new fellow at BCS, The Chartered Institute for IT and Warrington and Halton Teaching Hospitals NHS Foundation Trust appointing a new CIO.

Lee Rickles as become a fellow of BCS, The Chartered Institute for IT, in recognition of his leadership within digital health.

Rickles is the programme director at Yorkshire and Humber Care Record and CIO at Humber Teaching NHS Foundation Trust.

He said, “I am over the moon becoming a fellow of BCS and reflecting on my personal journey to be a national digital leader.

“As a leader, I am only as effective as my team and peers. I want to create an environment where my teams and peers continued their professional accreditation and development to get the NHS the digital workforce.  This is why I felt it was vital for the Yorkshire & Humber Care Record and Humber Teaching NHS Foundation Trust to become a BCS organisation.”

BCS is a charity which has over 60,000 members across 150 countries.  Its mission is to ensure everyone’s experience with technology is positive.


Warrington and Halton Teaching Hospitals NHS Foundation Trust has appointed Dr Tom Poulter as its  CIO.

Dr Poulter has spend the last four at Lancashire and South Cumbria Foundation Trust leading the regional implementation of the Rio EPR programme and Mental Health GDE [Global Digital Exemplar] Fast Follower Programme.

Poulter returns to the Cheshire & Merseyside Health & Care Partnership with his move to WHH in mid August, having previously worked in the region as CIO for Clatterbridge Cancer Centre.


MEDITECH has announced that Michelle O’Connor has been appointed as the organisation’s president and CEO.

Prior to this role, O’Connor served as president and chief operating officer. She takes over for Howard Messing, who is now vice chairman on the company’s board of directors.

MEDITECH has been an EPR provider in the UK and Ireland for 30 years, with customers spanning the NHS and private sector.

O’Connor said: “We have already seen first-hand how innovations such as the cloud and virtual care can make a huge difference for clinicians and the communities they serve. And collaborating with our great team of technology professionals, I know we will continue to innovate in ways that meet the evolving needs of our customers.

“As we look forward, I’m honoured to be leading MEDITECH into this next phase of our evolution.”


Health app company Ada has made a number of new appointments.

Gülsah Wilke, Torsten Schero and Vanessa Lemarié have been appointed the roles of Chief Operating Officer, Chief Financial Officer and Chief Client Officer respectively.

It is hoped the trio will be central to Ada’s business growth trajectory in their new roles, as the company accelerates its path towards becoming the world’s leading personalised operating system for health.

Daniel Nathrath, CEO & co-founder of Ada, said: “We couldn’t be happier to be welcoming Gülsah and Torsten to Ada, and to be welcoming Vanessa to the leadership team, as we enter a hugely exciting new chapter for the company.”

“These appointments put us in an excellent position to pursue our ambitious growth journey, expand our consumer and enterprise offerings, and transform the way people access healthcare for the better,” he added.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Movers and Shakers news roundup

Movers and Shakers news roundup

Our latest roundup features a new joint CEO of Chelsea and Westminster Hospital and The Hillingdon Hospitals NHS Foundation Trusts.
Moorfields Eye Hospital selects MEDITECH Expanse EPR

Moorfields Eye Hospital selects MEDITECH Expanse EPR

Moorfields Eye Hospital NHS Foundation Trust is to implement MEDITECH’s Expanse electronic patient record in its 20 locations around London.
Movers and Shakers news roundup

Movers and Shakers news roundup

Our latest Movers and Shakers roundup includes the abrupt departure of TPP’s long-serving clinical director, Dr John Parry.